glp 1 drugs wikipedia Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide-1 receptor - Wikipedia

This highlights tirzepatides potential as an alternative treatment for clinical outcomes related to HF management

28 A crucial tool to lower costs is swift generic competition, and addressing the patent and exclusivity landscape for drug-device combinations such as GLP-1 receptor agonists is key for facilitating such competition

The Rise of GLP1 Drugs for Weight Loss GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a revolutionary class of injectable or oral medications originally developed for type 2 diabetes, but now widely used for chronic weight management

Future research should further define their role in comprehensive hypertension management

Youve heard of GLP-1 medications but are hesitant to try them due to the side effects

References (this section): NEJM (2023): Phase 2 trial publication Eli Lilly: Phase 2 results (mentions 24.2% at 48 weeks as a secondary endpoint) Eli Lilly (Dec 2025): Phase 3 TRIUMPH-4 topline results announcement Retatrutide side effects: what trials report (not medical advice) Searches like retatrutide side effects and side effects of retatrutide usually refer to events reported in clinical trial publications and sponsor summaries